featured
Role of GLP-1 Receptor Agonists in Metabolic Dysfunction–Associated Steatohepatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis
Diabetes Obes Metab 2024 Mar 21;[EPub Ahead of Print], MF Abdelmalek, SA Harrison, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.